Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 501–600 of 749
Zhao, Y., Xiong, Z., Chen, Y., Wang, G., & Zhao, Y. (2021) · NeuroImmunoModulation · doi:10.1159/000515662 · Cited by 4
Cilenšek, I., Lapuh, V., Petrovič, M. G., & Petrovič, D. (2021) · Gene · doi:10.1016/j.gene.2021.145802 · Cited by 4
Changes in the blood complement system in the development of diabetic retinopathy in the elderly
Agarkov, N. M., Gorko, T. S., Institution, S. N. F. E. M. S., Лев, И. В., Institution, S. N. F. E. M. S., Shekaturov, A. A., & Shabalin, A. A. (2021) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2021-7-2-0-8 · Cited by 4
Sinclair, S. H., & Luttrull, J. K. (2022) · Journal of Ophthalmology Research Reviews & Reports · doi:10.47363/jorrr/2022(3)130 · Cited by 6
Asemi, Z., Salami, R., Salami, M., Mafi, A., Aarabi, M. H., & Vakili, O. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220829102020 · Cited by 7
Shah, D., Dhamankar, R., Shetty, V. D., Haldipurkar, S. S., Chipade, P., Tanwar, S., Sankhe, P., Venkatramani, D., Mhatre, P., & Setia, M. S. (2022) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v17i4.12303 · Cited by 4
“Thus, even though similar pathways of neuroretinal inflammation has been proposed in the retinal changes occurring from both glaucoma and diabetes,[41, 42] we did not find the parameters to be significantly altered due to diabetes in individuals with and without glaucoma.”
Chen, L., Li, T., & Ye, F. (2023) · International Ophthalmology · doi:10.1007/s10792-023-02636-y · Cited by 4
“G The production of IL-6 and TNF-α in the culture supernatant was analyzed by ELISA assay.”
BackgroundInfluentialLiao, L., Chen, J., & Peng, S. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2190055 · Cited by 5
“Moreover, an increasing number of studies have shown that inflammation is also a key player in DR development (Capitao and Soares 2016, Rubsam et al .”
González, V. H., Luo, C., Almeida, D. R. P., Cutino, A., Coughlin, B., Kasper, J. D., Kiernan, D. F., & PALADIN Principal Investigators: (2023) · Retina · doi:10.1097/iae.0000000000003827 · Cited by 4
Luo, X., Sun, J., Pan, H., Zhou, D., Huang, P., Tang, J., Shi, R., Ye, H., Zhao, Y., & Zhang, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289749 · Cited by 8
Lee, E. J., Lee, S., Jang, H., & Yoo, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010162 · Cited by 5
Role of MMP-9 in Diabetic Retinopathy
Mastari, E. S., Widjaja, S. S., Siregar, Y., & Sari, M. I. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i6-s.4635 · Cited by 4
Theriot, C. A., Chévez‐Barrios, P., Loughlin, T., Beheshti, A., Mercaldo, N. D., & Zanello, S. B. (2021) · Gravitational and Space Research · doi:10.2478/gsr-2021-0007 · Cited by 6
RANKL blockade suppresses pathological angiogenesis and vascular leakage in ischemic retinopathy
Ock, S., Park, S., Lee, J., & Kim, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.046 · Cited by 4
Oxidative stress in diabetic retinopathy
García‐Medina, J. J., Zanón‐Moreno, V., Pinazo-Duran, M. D., Foulquie-Moreno, E., Rubio-Velázquez, E., Casaroli-Marano, R. P., & del‐Río‐Vellosillo, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815776-3.00005-x · Cited by 4
Saunajoki, A., AUVINEN, J. P., Saarela, V. O., Uusitalo, J., Leiviskä, I. L., Keinanen-Kiukaanniemi, S. M., Liinamaa, J., & Timonen, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240983 · Cited by 4
Genetically engineered pigs manifesting pancreatic agenesis with severe diabetes
Nagaya, M., Hasegawa, K., Watanabe, M., Nakano, K., Okamoto, K., Yamada, T., Uchikura, A., Osafune, K., Yokota, H., Nagaoka, T., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001792 · Cited by 4
Singh, A., Sharma, I., Das, G., Sahu, P., & Rohatgi, J. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2606_21 · Cited by 4
“[5] Hyperglycemia is associated with activation of these microglial cells and their dysfunction is involved in the early retinal inflammatory response seen in DR.”
BackgroundInfluentialRetinal microglia-derived S100A9 incite NLRP3 inflammasome in a Western diet fed Ossabaw pig retinaPreprint
Lim, R. R., Thomas, A. E., Ramasubramanian, A., & Chaurasia, S. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.30.621160 · Cited by 6
Puddu, A., Nicolò, M., & Maggi, D. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041496 · Cited by 4
“This, in turn, results in an inflammatory environment that activates inflammatory cells, which contribute to exacerbation of the inflammatory process, thus creating a vicious cycle that increases both inflammation and oxidative damages to retinal cells [10,11].”
Targeting neurotrophic dysregulation in diabetic retinopathy: a novel therapeutic avenue
Rana, D. B., Dhankhar, S., Chauhan, R., Saini, M., Singh, R., Kumar, P., Singh, T. G., Chauhan, S., & Devi, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10671-4 · Cited by 5
Blegen, H. M. J., Justin, G. A., Bishop, B. A., Cox, A. R., Aden, J. K., Wedel, M. L., & Hobbs, S. D. (2021) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126421989576 · Cited by 3
Jiang, Y., Xing, X., Niu, T., Wang, H., Wang, C., Shi, X., Liu, K., & Li, S. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109283 · Cited by 3
Hector, S. M., Thulesius, H. O., Landin‐Olsson, M., Hillman, M., & Melin, E. O. (2023) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2023-001314 · Cited by 4
Huang, Q., Feng, D., Pan, L., Wang, H., Wu, Y., Zhong, B., Gong, J., Lin, H., & Fei, X. (2023) · PeerJ · doi:10.7717/peerj.16352 · Cited by 3
Georgescu, A., Dascălu, A. M., Stana, D., Alexandrescu, C. M., Bobirca, A. V., Cristea, B. M., VANCEA, G., Serboiu, C. S., Şerban, D., Tudor, C., et al. (2024) · Journal of Mind and Medical Sciences · doi:10.22543/2392-7674.1485 · Cited by 4
“The condition presents a complex physiopathological mechanism, with neuro-vascular, inflammatory and degenerative changes being described, which usually preceded the microangiopathic changes that are detectable by clinical examination [5-7].”
Therapeutic potential of flavopiridol in diabetic retinopathy: Targeting DDX58
Zhang, X., Hu, Q., Peng, H., Huang, J., Sang, W., Guan, J., Huang, Z., Jiang, B., & Sun, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112504 · Cited by 3
Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Mallamaci, F., & Zoccali, C. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14324 · Cited by 4
“64 68 Concurrently, adhesion molecules like ICAM-1 facilitate the adhesion of leukocytes to the endothelium, exacerbating the inflammatory response.”
Marinho, L. L., Ribeiro, M. L., Lawler, P. R., Iatan, I., Godoy, L. C., Rached, F. H., & Maranhão, R. C. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01292-0 · Cited by 3
“Those processes are closely associated with disruptions of the blood-retinal barrier, hypoxia, and increased vascular permeability, ultimately resulting in local edema and angiogenesis [75 ].”
Yu, H., Luo, L., Zhang, R., Xu, F., Yang, X., Wu, Y., Han, D., Chu, X., & Li, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s519725 · Cited by 4
“31 Microglia, as resident immune cells in the retina, participates in the occurrence and progenesis of retinal inflammation.”
Zeng, L., Wu, Y., Zhu, L., He, J., Yuan, Y., Wang, X., Tang, K., & Tan, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312791 · Cited by 5
Harley, O., Amelia, Y. S., Gustianty, E., Soetedjo, N. N. M., & Kartasasmita, A. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2517300 · Cited by 3
Cheng, S., Chen, Z., Peng, F., Deng, P., Wang, M., Liu, S., Du, Y., & Zuo, G. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s527784 · Cited by 5
“50 Müller cells are also a type of macroglial cells of the retina, which are unique to the fundus and play an important role in maintaining retinal homeostasis.”
Moemen, L. A., Ebeid, M. E.-S., Abdelazeem, A. A., Kenawy, M. K. M., & Osman, Z. M. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1908365 · Cited by 3
Hakim, N. Y. D. B. L., Noble, S., Thomas, N. V., Gamage, B. S. G., Ganeson-Koo, M., Govindasamy, V., Then, K.-Y., Das, A. K., & Cheong, S. (2022) · European Journal of Ophthalmology · doi:10.1177/11206721211073430 · Cited by 3
Effect of dexamethasone implant on intraocular cytokines in diabetic macular edema
Pillai, G. S., Gupta, A., Xavier, T., Radhakrishnan, N., Menon, K. N., Rasheed, R., & Ravindran, G. C. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1280_22 · Cited by 3
An overview of artificial intelligence use in diabetic retinopathy treatment: a narrative review
Sofy, A. A. (2023) · Futurity Medicine. · doi:10.57125/fem.2023.03.30.01 · Cited by 3
Dieter, C., Lemos, N. E., Corrêa, N. R. D. F., Assmann, T. S., Pellenz, F. M., Canani, L. H. S., Brondani, L. D. A., Bauer, A. C., & Crispim, D. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000624 · Cited by 3
“…these results suggest that serum TIE2 levels are not associated with DR, TIE2 activation has been investigated as a treatment or prevention strategy of DR, since TIE2 activation increased EC survival and adhesion, as well as cell-cell junction integrity, thereby stabilizing the vasculature (40,41).”
BackgroundCennamo, G., Montanaro, L., Massa, L., Malvone, E., & Costagliola, C. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103688 · Cited by 3
Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy
Poráčová, J., Nagy, M. S., Blaščáková, M. M., Konečná, M., Sedlák, V., Zahatňanská, M., Kimáková, T., Vašková, H., Rybárová, V., Majherová, M., et al. (2023) · Central European Journal of Public Health · doi:10.21101/cejph.a7838 · Cited by 8
Extracellular Vesicles and Diabetic Retinopathy: Nano-Sized Vesicles with Mega-Sized Hopes
Habib, S., Mansour, A., Baban, B., & Elmasry, K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005791 · Cited by 5
Retinal physiology in metabolic syndrome
García, D. M. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2024.11.002 · Cited by 4
Amin, R., Ansyori, A., Erna, R., & Fauzi, L. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4293 · Cited by 3
“Others study concluded that anti-RAGE treatment in diabetic retinopathy mice could lower pro-inflammatory cytokines such as NF-kβ and IL1β [3], [9], [10], [11], [12], [13].”
BackgroundThe Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation
Gurley, J. M., Gmyrek, G. B., Hargis, E. A., Bishop, G. A., Carr, D. J. J., & Elliott, M. H. (2021) · Cells · doi:10.3390/cells10082068 · Cited by 2
“Chronic retinal neurodegeneration, thus, leads to vision loss and, eventually, complete blindness [7,8].”
BackgroundZolfaghari, N., Monajemi, R., Shahanipour, K., & Ahadi, A. M. (2022) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.16727 · Cited by 3
Francelin, C., de Godoy, J. A. P., Qi, X., Silva, J. A. F., Grant, M. B., & Boulton, M. E. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05358-y · Cited by 3
“This would suggest that the SOD2 retinas release inflammatory factors such as the cytokines CCL2 and CXCL12, which are known to attract monocytes to areas of tissue damage [20, 22, 28].”
Background(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac125.66516667 · Cited by 3
“Hypoxia-inducible factor-1 rises in vitreous, which stimulates Muller cells, ultimately creating the chronic inflammatory environment and leading to accumulation and overexpression of fibroblast growth factor, ultimately leading to retinal fibrosis and pathological neovascularization [68].”
BackgroundEarly Neural Changes as Underlying Pathophysiological Mechanism in Diabetic Retinopathy
Cantó, A., Martínez-González, J., Perini-Villanueva, G., Miranda, M., & Bejarano, E. (2021) · International Journal of Translational Medicine · doi:10.3390/ijtm2010001 · Cited by 5
Mota-Silva, I., Castanho, M. A. R. B., & Silva-Herdade, A. S. (2023) · Life · doi:10.3390/life13040887 · Cited by 3
He, S., Gu, C., Meng, C., Cai, C., Lai, D., & Qiu, Q. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114496 · Cited by 2
Peng, J., Chen, Z., Wang, Y., Wang, K., Wu, F., & Xiang, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1602361 · Cited by 2
Deng, B., Nnebe, C., Prakhar, P., Ren, X., Sun, D., Sun, Y., & Wang, S. (2025) · Diabetes · doi:10.2337/dbi24-0009 · Cited by 6
Brown, D. M., Wolf, S., Veselovsky, M., Veith, M., Papp, A., Mange, S., Mondal, L. K., Romanczak, D., Jančo, L., Chauhan, R., et al. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01197-w · Cited by 2
“This damage can lead to capillary non‑perfu‑ sion, ischemia, and the production of vasoac‑ tive cytokines including hypoxia‑inducible fac‑ tor, vascular endothelial growth factor (VEGF), erythropoietin, and placental growth factor (PlGF) [1, 2].”
Zhang, X., Dong, J., Lu, H., Sun, M., Xu, S., Zhang, Y., Peng, Y., Sun, D., & Jiang, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1673884 · Cited by 2
Li, R.-R., Lv, L.-N., Li, H., Wang, J., Wang, Y. X., Gao, J.-K., Zhou, C.-Q., Wang, Y.-C., & Wei, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-23067-y · Cited by 2
“…to VEGF, TNF-α, IL-1α, IL-1β, IL-6, IL-8, IL-10, ICAM-1, MCP-1, placental growth factor (PlGF), hepatocyte growth factor (HGF), insulin-like growth factor-1 (IGF-1), and histamine and complement factors, which were reported to be upregulated in the vitreous or aqueous humor of DME patients 6,7 .”
Sarkar, S., Kannan, R., Panigrahi, T., Veeramani, K., Thirumalesh, M. B., Bhattacharya, S. S., & Ghosh, A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08257-w · Cited by 3
Lin, C., Ye, W., Wu, S., & Huang, Z. (2025) · Biomedicines · doi:10.3390/biomedicines13122979 · Cited by 3
“Chronic hyperglycemia induces metabolic stress in retinal glia, endothelial cells, and RPE, triggering the release of cytokines (e.g., IL-6, IL-1 β , TNF-α ) [9,40,41], chemokines (MCP-1) [42], matrix metalloproteinases (MMP-9), and complement components [43,44].”
Cho, M., Lee, J., Kim, Y., Kim, Y. J., Doğuer, Ç., Kim, M., & Ha, J. (2026) · Journal of Medicinal Food · doi:10.1177/1096620x251412888 · Cited by 2
Wall, K., Arend, L. P., von der Emde, L. A., Jauch, A. S., Holz, F. G., Saßmannshausen, M., & Ach, T. (2026) · Scientific Reports · doi:10.1038/s41598-025-34931-2 · Cited by 2
Proteolytic remodelling of the extracellular matrix by pericytes
Burkhard, T., Milne, E., Qian, K., Campagnolo, P., & Santamaria, S. (2026) · FEBS Journal · doi:10.1111/febs.70569 · Cited by 3
Zhao, C., Qin, L., Zhang, J., & Wang, X. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11213-6 · Cited by 3
Hub Genes Associated with the Diagnosis of Diabetic Retinopathy
Tang, Y., Tang, Q., Wei, H., Hu, P., Zou, D., Liang, R., & Yu, L. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s311683 · Cited by 2
“Animal studies have shown that hyperglycemia can cause vascular dysfunction in DR,(53) while inflammation has also been indicated as a key factor in the development of DR.(54) However, here, we found that chronic inflammation is suppressed during DR, suggesting that the inflammatory response of in vitro cultured DR ce…”
BackgroundKonovalova, K. I., Shishkin, M. M., & Fayzrakhmanov, R. R. (2021) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2021-14-3-14-18 · Cited by 2
Involvement of High Mobility Group Box 1 Protein in Optic Nerve Damage in Diabetes
Mohammad, G., & Kowluru, R. (2022) · Eye and Brain · doi:10.2147/eb.s352730 · Cited by 2
“Similarly, RNFL, considered as a sensitive indicator for the assessment of optic nerve health and injury, often progressively degenerates before the onset of diabetic retinopathy,(7,8,56) and inflammation is considered as one of the key components of diabetes induced ocular complications contributing in chronic neurod…”
BackgroundAdiponectin: A “Friendly adipokine” in Diabetic Retinopathy?
Pansani, V. F., Celim, L. B. D., Oliveira, G. A., & Degasperi, G. R. (2023) · Seminars in Ophthalmology · doi:10.1080/08820538.2023.2205929 · Cited by 3
“in endothelial and glial cells producing inflammatory cytokines, exacerbating the inflammatory response.(40) In animal models, adiponectin has been shown to reduce new vessel formation in the retina subjected to hypoxia.”
BackgroundNourinia, R., Nouri, H., Abtahi, S.-H., Nakao, S., Eslamipour, J., Gerami, E., & Ahmadieh, H. (2023) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2023.03.034 · Cited by 2
Serum neopterin and orexin-A levels in different stages of diabetic retinopathy
Alkan, A. A., Arslan, B., Özcan, D., & Tekin, K. (2024) · Clinical and Experimental Optometry · doi:10.1080/08164622.2024.2374875 · Cited by 2
Morales-López, Ó., Rodríguez‐Cortés, O., López‐Sánchez, P., Pérez-Cano, H. J., García-Liévanos, O., Lima-Gómez, V., & Somilleda-Ventura, S. A. (2024) · BMC Ophthalmology · doi:10.1186/s12886-024-03659-4 · Cited by 2
“It has been described that retinal damage due to inflammation is related to the degranulation of glial cells and the extravasation of cytokines and growth factors, which generates a recurring cycle of damage and inflammation that wears down the retinal tissue [15, 16].”
BackgroundNagel, I. D., Mueller, A., Freeman, W. R., & Kozak, I. (2024) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2418-5173 · Cited by 2
Yang, Y. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102620 · Cited by 2
Ugwueze, C. V. (2025) · Journal of Diabetology · doi:10.4103/jod.jod_101_24 · Cited by 4
Liu, M., Luo, T., Li, R., Yin, W., Yang, F., Ge, D., & Liu, N. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60827-2 · Cited by 2
Yue, J., Luo, L., Guo, M., & Xu, C. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.128816 · Cited by 3
Pathomechanismen der diabetischen Retinopathie
Agostini, H. T., Martin, G., & Ziemssen, F. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0409-9 · Cited by 2
Grigsby, J. G., & Derbel, F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83159 · Cited by 2
Dascălu, A. M., Şerban, D., Παπάνας, Ν., Kempler, P., Rizzo, M., Stana, D., Román, G., & Stoian, A. P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96548 · Cited by 3
葛, 朋. (2019) · Hans Journal of Ophthalmology · doi:10.12677/hjo.2019.81008 · Cited by 2
Wooff, Y., Cioanca, A. V., Chu‐Tan, J. A., Aggio‐Bruce, R., Schümann, U., & Natoli, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.29.014910 · Cited by 3
Zuo, X., Bai, H., Zhao, Q., Zhao, X. J., & Feng, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4463938/v1 · Cited by 2
Yılmaz, M., Çıtırık, M., Rahmanlar, H., Alkan, A., & Gürsöz, H. (2022) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2022.56 · Cited by 1
“These mediators induce increased vascular permeability in the retina, retinal/ disc neovascularization, intraretinal/ intraocular hemorrhages, and ultimately vision loss [4,5].”
BackgroundDiabetes Mellitus Associated Progressive Neurovascular Retinal Injury
Sinclair, S. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-25779-7_18 · Cited by 2
Horecha, M. Y., Sarakhman, D. M., & Лаповец, Л. Е. (2024) · Ukrainian Journal of Laboratory Medicine · doi:10.62151/2786-9288.2.2.2024.07 · Cited by 1
Current perspectives in the management of diabetic macular edema
Rathod, K., Manayath, G. J., & Narendran, V. (2024) · Haryana Journal of Ophthalmology · doi:10.4103/hjoo.hjoo_10_24 · Cited by 1
Zhang, S., Song, W., Huang, B., Wang, T., & Sun, C. (2024) · Technology and Health Care · doi:10.1177/09287329241296705 · Cited by 1
Role of Apoptosis in Diabetes: Therapeutic Targets and Strategies
Bar, S., Dhara, S., Halder, S., Jana, K., & Ghorai, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_12 · Cited by 1
Lights and Shadows of Cytokines in Age‐Related Eye Diseases: A Narrative Literature Review
Xue, Y., Ye, L., Huang, C., & Ye, H. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70121 · Cited by 2
“The levels of these molecules are especially elevated in the ocular fluid of diabetic patients [53 – 55].”
Salehi, A., Malekahmadi, M., Ghanbari, H., & Ghazi, M. (2025) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_656_24 · Cited by 2
Tundo, G. R., Atzori, M. G., Boccaccini, A., Cavaterra, D., Bocedi, A., Graziani, G., Marini, S., Lacal, P. M., Villa, M., Pricci, F., et al. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02543-x · Cited by 2
Characterisation of vitreous derived small extracellular vesicles in diabetic retinopathy
Louie, H. H., Rupenthal, I. D., Lim, J. C.-H., Chamley, L. W., & Mugisho, O. O. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110654 · Cited by 1
Kaur, G., Bisen, S., Sharma, A., & Singh, N. K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00308.2025 · Cited by 3
Hor, M. S., Rahgozar, S., Souri, Z., & Malekahmadi, M. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03807-9 · Cited by 1
“…of several major retinal complications, including diabetic retinopathy (DR) and its vision-threatening complication, diabetic macular edema (DME) [5], as well as branch retinal vein occlusion (BRVO) [6], central retinal vein occlusion (CRVO) [7], and neovascular age-related macular degeneration…”
Zahavi, A., Weiss, S., dbai, J. A., Salti, T., & Goldenberg‐Cohen, N. (2025) · Diabetology · doi:10.3390/diabetology6110132 · Cited by 1
Ambrósio, J. A., Cardoso-Teixeira, P., Garcia, M. B., Chibante-Pedro, J., & Ruão, M. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01277-x · Cited by 1
“Corticosteroids, such as intravitreal triamci‑ nolone or dexamethasone implants, provide an alternative option, particularly for patients who are insufficiently responsive to anti‑VEGF agents or in whom inflammatory mechanisms are thought to play a more prominent role [17–19].”
Wang, Y., Zhang, Y., Lu, Q. R., & Zhao, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02029-4 · Cited by 2
“In a hyperglycemic environment, immune cells become activated and release large quantities of inflammatory mediators, triggering a sustained inflammatory response in retinal tissues [13].”
Gui, S., Gao, J., Tao, T., Wang, P., Huang, Z., She, Y., Li, J., Su, J., Lu, Z., Qiao, J., et al. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70085 · Cited by 1
Lee, Y., & Yang, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119035 · Cited by 2
Ahmed, M. S., & Manirujjaman, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11605-4 · Cited by 2
Inflammatory Biomarkers in Diabetic Macular Edema
Campos, A., Furtado, M. J., Carneiro, Â., Meireles, A., Marques‐Neves, C., Ambrósio, A. F., Leal, I., Figueira, J., Marques, J. P., Henriques, J., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051949 · Cited by 1
Zeppieri, M., Drigo, A., Capobianco, M., Visalli, F., Cappellani, F., Musa, M., Giglio, R., Tognetto, D., Khouyyi, M., Gagliano, C., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.114603 · Cited by 1
Yang, F., Gong, Y., Pan, X., Zhao, J., Yu, R., Tan, L., Pazo, E. E., Zhang, X., & Li, X. (2026) · Eye and Vision · doi:10.1186/s40662-026-00479-z · Cited by 2
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.